The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis

Journal of Neurochemistry
Natalie A Prow, David N Irani

Abstract

Astrocytes remove glutamate from the synaptic cleft via specific transporters, and impaired glutamate reuptake may promote excitotoxic neuronal injury. In a model of viral encephalomyelitis caused by neuroadapted Sindbis virus (NSV), mice develop acute paralysis and spinal motor neuron degeneration inhibited by the AMPA receptor antagonist, NBQX. To investigate disrupted glutamate homeostasis in the spinal cord, expression of the main astroglial glutamate transporter, GLT-1, was examined. GLT-1 levels declined in the spinal cord during acute infection while GFAP expression was preserved. There was simultaneous production of inflammatory cytokines at this site, and susceptible animals treated with drugs that blocked IL-1beta release also limited paralysis and prevented the loss of GLT-1 expression. Conversely, infection of resistant mice that develop mild paralysis following NSV challenge showed higher baseline GLT-1 levels as well as lower production of IL-1beta and relatively preserved GLT-1 expression in the spinal cord compared to susceptible hosts. Finally, spinal cord GLT-1 expression was largely maintained following infection of IL-1beta-deficient animals. Together, these data show that IL-1beta inhibits astrocyte glutama...Continue Reading

References

May 28, 1992·The New England Journal of Medicine·J D RothsteinR W Kuncl
Jul 1, 1995·Annals of Neurology·J D RothsteinR W Kuncl
Mar 15, 1996·The Journal of Biological Chemistry·D TrottiA Volterra
Aug 1, 1997·Journal of Neuropathology and Experimental Neurology·S LiE Masliah
Dec 29, 1999·Nature Medicine·T SmithL Turski
Dec 29, 1999·Nature Medicine·D PittC S Raine
Jan 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·David S HowlandJeffrey D Rothstein
Apr 19, 2002·Journal of Neuroimmunology·Makoto OhgohYukio Nishizawa
Mar 30, 2004·Annals of Neurology·Jennifer L Nargi-AizenmanDiane E Griffin
Aug 27, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jessica DarmanDouglas A Kerr
Nov 24, 2004·Lancet Neurology·V Wee YongLuanne M Metz
Mar 11, 2005·Brain : a Journal of Neurology·Radhika SrinivasanDaniel Pelletier
Mar 26, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Liya QinJau-Shyong Hong
Jul 28, 2005·Journal of Neurochemistry·Marco I GonzálezMichael B Robinson
Aug 27, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Thomas KornStefan Jung
Apr 21, 2006·Biochimica Et Biophysica Acta·Katie Moisse, Michael J Strong
Jun 3, 2006·Science·Séverine BoilléeDon W Cleveland
Sep 20, 2006·Annals of Neurology·Larry E DavisKenneth L Tyler
Dec 2, 2006·The Journal of Biological Chemistry·Guilian TianChien-Liang Glenn Lin
Apr 4, 2007·Journal of Neurochemistry·Steven W BargerMarjorie L Beggs
May 15, 2007·Journal of Neuroscience Research·Sébastien Tilleux, Emmanuel Hermans
Jun 6, 2007·Journal of Neuropathology and Experimental Neurology·David N Irani, Natalie A Prow
Aug 28, 2007·The Journal of Comparative Neurology·Alain R Simard, Serge Rivest

❮ Previous
Next ❯

Citations

May 28, 2013·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Holly M BrothersGary L Wenk
Oct 6, 2009·Pharmacogenetics and Genomics·Liang LiuJanet K Coller
May 25, 2012·Journal of Virology·Stephanie A SchittonePenny Clarke
Dec 5, 2012·PLoS Pathogens·Hilario J RamosMichael Gale
Dec 24, 2013·Metabolic Brain Disease·Lindsay T Michalovicz, Gregory W Konat
Feb 26, 2015·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Erin R HascupAndrzej Bartke
Nov 18, 2009·Journal of Neuropathology and Experimental Neurology·Pennelope K BlakelyDavid N Irani
Apr 6, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yong-Ku Kim, Kyoung-Sae Na
Jul 26, 2014·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Masashi SakuraiTakehito Morita
Oct 2, 2014·Journal of Neurochemistry·Georgi Gegelashvili, Ole J Bjerrum
Sep 25, 2012·Journal of Neuroimmunology·Di MaAkio Suzumura
Mar 29, 2014·European Journal of Microbiology & Immunology·L MöhleI R Dunay
Jun 18, 2016·Mediators of Inflammation·Tobias DahmTobias Tenenbaum
Oct 21, 2016·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Egle Cekanaviciute, Marion S Buckwalter
Feb 7, 2017·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Jay StarkeyToshio Moritani
Jan 8, 2018·Reviews in the Neurosciences·Elena D OsipovaAlla B Salmina
Dec 3, 2016·Journal of Virology·Luiza A Castro-JorgeKatherine R Spindler
Jan 1, 2010·International Journal of Emergency Medicine·Carlos Garcia-GubernDaniel Masvidal
Jun 11, 2008·The Journal of Biological Chemistry·Michelle A SamaChristopher M Norris
Nov 30, 2018·The Journal of Pharmacology and Experimental Therapeutics·Yunshan ZhangYanguo Hong
Jan 5, 2020·Journal of Neuroinflammation·Hugo Charles-MessanceXavier Guillonneau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.